Amersham recovers in second half
This article was originally published in Clinica
Executive Summary
Amersham recovered from a flat first half to record an 8% increase in pretax profit to £50.8 million ($76.2 million) on turnover up 5% to £351.4 million in the year ended March 31st, 1996. The UK group's healthcare division reported 10% growth in turnover to £141.3 million, benefiting from a full year's sales of Myoview in Europe and Japan.